Ethics
vs. Scientific Progress:
The
Benefits of Stem Cell Research Outweigh Risks
Zumana
Miyfa
ENG
21003, Section C
Professor
Nargiza Matyakubova
March 8, 2014
Ethics
vs. Scientific Progress:
The
Benefits of Stem Cell Research Outweigh Risks
Imagine living with an ailing
disease, such as Parkinson’s, diabetes, or even cancer. These are only some of
the illnesses that numerous individuals must deal with on a daily basis. Would
it be wrong for scientists to be allowed to conduct groundbreaking research
that could treat these diseases more effectively and lead to possible cures?
The clear answer to this question is absolutely not. It should be permissible
for researchers to conduct stem cell research because the advances made in the
field of medicine outweigh the risks and ethical dilemma concerning this type
of research.
What
is Stem Cell Research?
The controversial debates over stem
cell research began when stem cells were first discovered in the late 1900s. According
to Haldeman-Englert (2012), “A stem cell is generic cell that can make copies
of itself indefinitely” (p. 1). These unique cells are fundamental for the
revolutionary type of research known as “stem cell research” because they can
multiply at a quick rate and create specialized cells for various types of
tissues that the human body needs, such as brain tissue, heart muscle, and
liver tissue. The cells can be stored away and used when specialized cells are necessary
as well.
There
are also two basic types of stem cells: embryonic stem cells and adult stem
cells. Embryonic stem cells (ES cells) are “taken from aborted fetuses or
fertilized eggs that are left over from in vitro fertilization (IVF)”
(Haldeman-Englert, 2012, p. 1). The ES cells are useful for research and medical
purposes because they can produce cells for almost any part of the body. On the
other hand, adult stem cells are specific to certain cell types and cannot be
used as effectively for conducting research. Adult stem cells can be found in
both adults and children, but they consist of blood, intestine, skin, and
muscle cell types (Badge, 2001, p. 85). Therefore, adult stem cells are not as
versatile as embryonic stem cells, which can lead to finding cures for
various
diseases.
Two significant breakthroughs have
emerged as a result of stem cell research, and it is necessary for further
research to be conducted in order to make even more discoveries. Those
breakthroughs are “animal cloning by Ian Wilmut, Keith Campbell and
colleagues and the derivation of pluripotent human embryonic stem (ES) cells by
Jamie Thomson and co-workers” (Badge,
2001, p. 88). Animal cloning is an advancement in stem cell research
because if animals could be cloned, then there is potential for human body
parts and organs to be cloned and used to cure individuals who have heart
problems or kidney failure. Thomson’s discovery of pluripotent human ES cells
is also essential because pluripotent embryonic stem cells are found in
implanted embryos, fetuses, and developed organisms; these are the cells that
have the ability to become all cell types. Therefore, his research on ES cells
is the building block for future stem cell research since the pluripotent cells
can form various tissues that the body needs.
The “combining [of these] two in the process
of ‘therapeutic cloning’, whereby ES cells could be derived from a patient’s
cell,” solves the dire “problems of immune rejection” (Badge, 2001, p. 88). Therapeutic cloning can result in the
curing many diseases because the human body would not reject the cloned
embryonic stem cells whereas the body often rejects cells if organs are donated
from other individuals. The ES cells are also “one of the easiest types to grow
… which are those with the greatest potential” (Badge, 2001, p. 89). Therefore,
the embryonic stem cells are the most necessary for research because they are
the ones that will be able to treat and cure cell-related illnesses.
Risks
of Embryonic Stem Cell Research
Beeson (2006) stated that, “young
women are being asked to donate or sell their ova, not only for use in
fertility clinics, but increasingly for non-clinical use in experimental
cloning research” (p. 1). When women donate or cell their eggs for experiment
research, they are given hormonal drugs that may have short-term and long-term
effects on their health. However, this issue can easily be solved through
better regulation of the hormonal drugs that are administered to the ova
donors. Women could also be properly advised regarding how those drugs will
affect their bodies, and the option of donating or selling ova should be
determined by those women solely since they have the freedom to do what they
want with their own bodies.
Ethical
Dilemma Regarding Stem Cell Research
A common misconception is that stem
cell research is unethical because it goes against religious doctrines in which
God or a higher power is meant to create human life. However, the utilizing of
stem cells to cure illnesses does not infringe on religion at all. Scientists
are not creating new life; they are simply allowing embryonic stem cells to
duplicate and become specialized cells that can provide properly functioning
organs and body parts to those in need. It is certainly not ethical to make it
difficult for researchers to obtain embryonic stem cells since the research
studies would be benefitting the greater good, and religious practice promotes
helping those who are in need of aid.
Another fallacy is that “collection
of eggs for embryo cloning research is being conducted in the context of an international
race for dominance in … the production of embryonic stem cells and related
products that may result in substantial private financial gain while offering
no therapeutic benefits” (Beeson, 2006, p. 1). In reality, embryonic stem cell
research and stem cell research in general is not meant for corporations,
public or private, to make financial gains. On the contrary, corporations and
the federal government should be providing researchers with sufficient money in
order to conduct further stem cell research. Therefore, the argument that ES
cell studies “result in substantial private financial gain while offering no
therapeutic benefits” is invalid because there are various benefits that stem
cell research may provide to people.
Benefits
of Stem Cell Research
According to Solter (2006), “The
derivation of the first human ES cell lines and human embryonic germ-cell lines
lagged significantly behind their mouse counterparts” (p. 324). Cell research
is primarily conducted on mice since it is difficult for researchers to obtain
human embryos and fetuses for stem cell research due to “potential legal
problems and political and moral dilemmas” (Solter, 2006, p. 324). However, in
comparison to the results from the mice experiments, the experiments conducted on
human ES cells have shown that the human cells are more applicable to the human
body in terms of curing diseases that people contract. Therefore, ES cell
research is beneficial to people because specialized cells that can be created
from the stem cells have been proven to efficiently treat Parkinson’s disease.
Parkinson’s
disease is a motor systems disorder, in which nerve cells in the brain that are
supposed to produce a chemical called dopamine break down (Landis, 2012, p. 1).
The absence of those nerve cells result in tremor (excessive shaking or
trembling), stiff muscles, slow movement, and/or problems walking. Although
there is no cure for this diseases, stem cell “tissue transplantation has shown
beneficial effects on some patients by long‐term reduction in clinical
symptoms such as tremors, bradykinesia (slowness of movement), akinesia
(absence of normal movement) and postural impairment” (Master, McLeod, and
Mendez, 2007, p.4). Therefore, stem cell research directly benefits those who
suffer from the incurable Parkinson’s disease by reducing the symptoms and
discomfort that the illness causes and by decreasing the amount of drugs that
individuals need to take to treat Parkinson’s.
In addition
to treating Parkinson’s disease effectively, embryonic stem cell research can also
lead to progress in finding the cure for cancer. Huntly and Gilliland (2005)
are two researchers who have developed the theory that cancerous tumors are
results of “cancer stem cells,” which are cells in the embryo or fetus that
mutate and spread as tumors. These two men noted the following:
A cancer stem cell would function in a
similar way to sustain the growth and spread of tumours while repopulating the
distinct cell types represented within the tumour. However, a cancer stem cell
would not be subject to the same intrinsic and extrinsic controls as normal
stem cells. This ‘cancer-stem-cell hypothesis’ represents a modern-day
interpretation of the proposal made by pathologists such as Rudolph Virchow and
Julius Cohnheim ~150 years ago that cancer results from the activation of
dormant embryonic-tissue remnants. (p. 311)
Huntly and
Gilliland expanded upon the original “cancer-stem-cell hypothesis” that Virchow
and Cohnheim proposed. The prevalent theory is that tumors develop from the
cells that mutate within the embryo. However, ES cell research can help
determine exactly which cells would be likely to cause cancer and discover
potential ways to change those cells. In terms of treating those who are
battling cancer, stem cells can be implanted in order to replace the tumors
that must be removed and the human body would not be as susceptible to
rejecting those cells. Further research could ensure that those stem cell
transplants prevent cancer from returning in the long run.
The Bigger Picture
Ultimately, stem cell research leads
to greater benefits for individuals and for society while causing minimal harm
to women who donate their ova. The major benefits of embryonic stem cell
research are that it effectively treats malign diseases, such as Parkinson’s
and cancer, and has the potential for scientists to clone the cells in order to
form fully functioning organs and body parts for people who need transplants.
Ethics should not deter scientists from conducting further ES cell research. In
fact, the world needs more researchers and egg cell donors who are willing to
contribute to innovative stem cell research and take the future of medicine
into their own hands.
Reference
Badge, R. (2001). The Future For
Stem Cell Research. In MRC National Institute for Medical
Research
Publications. Retrieved from
http://www.ibt.unam.mx/computo/pdfs/cursosviejos/bcelularII02/bcelular/Nature%20414_88%20stem-rev.pdf
Beeson, D. (2006). Egg Harvesting
For Stem Cell Research: Medical Risks And Ethical
Problems. In Reproductive BioMedicine Online
Publications. Retrieved from
http://download.journals.elsevierhealth.com/pdfs/journals/1472-6483/PIIS1472648310606475.pdf
Halderman-Englert, C. (2012). Stem
Cell Research. In University of Maryland
Medical Center
Publications Online. Retrieved from
http://umm.edu/health/medical/ency/articles/stem-cell-research
Huntly, B., and Gilliland, G.
(2005). Leukaemia Stem Cells And The Evolution Of Cancer-Stem-
Cell Research. In Nature Reviews: Cancer Publications and
PubMed Databases.
Retrieved from
http://groups.molbiosci.northwestern.edu/mayo/Paper%20pdfs/Huntly%20et%20al%20LSC.pdf
Landis,
S. C. (2012). NINDS Parkinson's Disease
Information Page. In National
Institute of Neurological Disorders and Stroke Publications Online. Retrieved
from
http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm
Master, Z., McLeod, M., and Mendez,
I. (2007). Benefits, Risks And Ethical Considerations In
Translation Of
Stem Cell Research To Clinical Applications In Parkinson's Disease. In
Journal of Medical Ethics Publications. Retrieved
from
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2598267/
Solter,
D. (2006). From Teratocarcinomas To Embryonic Stem Cells And Beyond: A History
Of Embryonic Stem Cell Research. In
Nature Reviews: Genetics Publications and PubMed Databases. Retrieved from
http://mcb5068.wustl.edu/MCB/Lecturers/Huettner/Reading%20pdf/Solter06_NatureRevGenet.pdf
No comments:
Post a Comment